Foslevodopa/foscarbidopa: a new subcutaneous treatment for Parkinson's disease. Rosebraugh M, Voight EA, Moussa EM, Jameel F, et al. Ann Neurol 2021 Mar 26. doi: 10.1002/ana.26073.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rosebraugh M, Voight EA, Moussa EM, Jameel F, et al. Foslevodopa/foscarbidopa: a new subcutaneous treatment for Parkinson's disease. Ann Neurol 2021 Mar 26. doi: 10.1002/ana.26073.
PMID: 33772855